CANTON, Mich. (12/8/2021) - MMS Holdings, a data-focused CRO, is pleased to announce its selection as Best Contract Research Organization – Specialist Providers in the 2021 Scrip Awards. The Scrip Awards, held annually by London-based Informa Pharma...
MMS Holdings Expert Insights Blog
Experts at MMS share their insights on trending
topics in the pharmaceutical industry.
Former Astellas VP of Biostatistics Joins MMS as Principal Advisor of Biostatistics
CANTON, Mich. (November 18, 2021) – MMS Holdings – a data-focused CRO – announced this week the addition of Kevin Chartier, Ph.D., as Principal Advisor of Biostatistics and Submissions Planning. Chartier will work with the biostatistics team across MMS global...
MMS Holdings is the Winner of The Michigan Top Workplaces 2021 Award
CANTON, Mich. (11/15/2021) – MMS has been named a 2021 award winner of the Michigan Top Workplaces by the Detroit Free Press Top Workplaces. The award is based solely on employee feedback from an anonymous survey measuring 15 culture drivers that are critical to the...
Praxis bioresearch seeks support from MMS for Alzheimers Disease Therapeutics
SACRAMENTO, Calif. (October 28, 2021) - MMS Holdings (MMS) – a data-focused CRO – provided regulatory strategy support to Praxis Bioresearch in the development of a therapeutic for apathy in Alzheimer’s disease. This comes as Praxis was awarded a $2.9 Million...
MMS SmartStart™ Tech-Enabled Solution Eases Document Content Creation Process
CANTON, Mich. (September 22, 2021) - MMS Holdings Inc. (MMS) - an award-winning, data-focused CRO – announced the release of SmartStart™ Tech-Enabled Templates to reduce time and effort in the document content creation process while increasing the quality...
Pro-Bono Ultra-rare Disease Regulatory Assistance Program Created By MMS for Patient Advocacy Groups
CANTON, Mich. (August 12, 2021) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today the launch of its pro-bono support program aimed at advancing research for ultra-rare diseases. Within this program, MMS will select from patient advocacy...
Data CRO Expands its Virtual Learning Portfolio
Data CRO Expands its Virtual Learning Portfolio with New Life Sciences Courses in Inspection Readiness and Clinical Programming CANTON, Mich. (July 28, 2021) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced that its learning arm, MMS Academy, has...
MMS Poised for an Innovative Future with Best Clinical Research Organization Award and Two Key Executive Appointments
CANTON, Mich. (July 21, 2021) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO - announced the growth of its leadership team with the appointment of Kelly J. Hill to Executive Vice President (EVP) of Global Business Operations and Strategy and Michelle...
Health Data Research UK Selects MMS as Data Services Partner for the International COVID-19 Data Alliance
LONDON (July 15, 2021) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today that it has been selected by Health Data Research UK (HDR UK) – the national institute for health data science – as a partner to support the International COVID-19...